These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15502323

  • 1. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
    Kammerer S, Germain P, Flaig R, Peluso-Iltis C, Mitschler A, Rochel N, Gronemeyer H, Moras D.
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
    Klaholz BP, Mitschler A, Moras D.
    J Mol Biol; 2000 Sep 08; 302(1):155-70. PubMed ID: 10964567
    [Abstract] [Full Text] [Related]

  • 3. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D.
    J Mol Biol; 2001 Mar 23; 307(2):557-76. PubMed ID: 11254382
    [Abstract] [Full Text] [Related]

  • 4. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor.
    Bourguet W, Ruff M, Bonnier D, Granger F, Boeglin M, Chambon P, Moras D, Gronemeyer H.
    Protein Expr Purif; 1995 Oct 23; 6(5):604-8. PubMed ID: 8535152
    [Abstract] [Full Text] [Related]

  • 5. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.
    Rochel N, Renaud JP, Ruff M, Vivat V, Granger F, Bonnier D, Lerouge T, Chambon P, Gronemeyer H, Moras D.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):293-6. PubMed ID: 9016769
    [Abstract] [Full Text] [Related]

  • 6. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
    Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV.
    Nature; 1998 Sep 10; 395(6698):137-43. PubMed ID: 9744270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overexpression, purification, and crystal structure of native ER alpha LBD.
    Eiler S, Gangloff M, Duclaud S, Moras D, Ruff M.
    Protein Expr Purif; 2001 Jul 10; 22(2):165-73. PubMed ID: 11437591
    [Abstract] [Full Text] [Related]

  • 10. Crystallization and preliminary crystallographic studies of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.
    Razeto A, Pfitzner E, Becker S.
    Acta Crystallogr D Biol Crystallogr; 2004 Mar 10; 60(Pt 3):550-2. PubMed ID: 14993689
    [Abstract] [Full Text] [Related]

  • 11. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M, Vivat V, Wurtz JM, Losson R, Chambon P, Moras D, Gronemeyer H.
    Chem Biol; 1999 Aug 10; 6(8):519-29. PubMed ID: 10421757
    [Abstract] [Full Text] [Related]

  • 12. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis.
    Bourguet W, Andry V, Iltis C, Klaholz B, Potier N, Van Dorsselaer A, Chambon P, Gronemeyer H, Moras D.
    Protein Expr Purif; 2000 Jul 10; 19(2):284-8. PubMed ID: 10873543
    [Abstract] [Full Text] [Related]

  • 13. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL.
    Nat Struct Biol; 2002 May 10; 9(5):359-64. PubMed ID: 11953755
    [Abstract] [Full Text] [Related]

  • 14. Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain.
    Nunes FM, Aparicio R, Santos MA, Portugal RV, Dias SM, Neves FA, Simeoni LA, Baxter JD, Webb P, Polikarpov I.
    Acta Crystallogr D Biol Crystallogr; 2004 Oct 10; 60(Pt 10):1867-70. PubMed ID: 15388935
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.
    Wang W, Prosise WW, Chen J, Taremi SS, Le HV, Madison V, Cui X, Thomas A, Cheng KC, Lesburg CA.
    Protein Eng Des Sel; 2008 Jul 10; 21(7):425-33. PubMed ID: 18456871
    [Abstract] [Full Text] [Related]

  • 18. Structure of human TSG101 UEV domain.
    Palencia A, Martinez JC, Mateo PL, Luque I, Camara-Artigas A.
    Acta Crystallogr D Biol Crystallogr; 2006 Apr 10; 62(Pt 4):458-64. PubMed ID: 16552148
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
    Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P, Moras D.
    EMBO J; 2000 Jun 01; 19(11):2592-601. PubMed ID: 10835357
    [Abstract] [Full Text] [Related]

  • 20. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X, Maruo T, Cao Y, Punj V, Mehta R, Das Gupta TK, Christov K.
    Cancer Res; 2004 Dec 15; 64(24):8911-8. PubMed ID: 15604252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.